Masimo Stock

Masimo Days Payable Outstanding

Delisted·Jun 12, 2026

The Days Payable Outstanding (DPO) of Masimo (MASI) as of Aug 22, 2026 is 64.63. In the previous year, Days Payable Outstanding (DPO) was 84.65 — a change of -23.65% (lower).

Days Payable Outstanding

64.63

YoY

-23.65%

Last updated:

Days Payable Outstanding (DPO) of Masimo is 2026 64.63 . Days Payable Outstanding (DPO) of Masimo was 2025 84.65 . It decreases by -23.65% lower compared to the previous year.

The Masimo Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2018
52.02 USD
Jan 1, 2019
64.50 USD
Jan 1, 2020
58.35 USD
Jan 1, 2021
64.05 USD
Jan 1, 2022
103.41 USD
Jan 1, 2023
87.88 USD
Jan 1, 2024
84.65 USD
Jan 1, 2025
64.63 USD
The Masimo Days Payable Outstanding history
YEARDays Payable OutstandingYoY
64.63-23.65%
84.65-3.67%
87.88-15.02%
103.41+61.45%
64.05+9.77%
58.35-9.53%
64.50+24.00%
52.02+13.16%
45.97-13.96%
53.43+24.58%
42.89-39.51%
70.90
Access this data via the Eulerpool API

Masimo Stock analysis

What does Masimo do? Masimo Corporation is an American medical technology company based in Irvine, California. The company was founded in 1989 by Professor Joe Kiani, who is still the chairman and CEO of the company today. With innovative products and advanced technology, Masimo aims to optimize medical diagnostic and treatment procedures to improve patient care. The business model of Masimo Corp focuses on developing and marketing products and solutions for patient monitoring and treatment in hospitals, intensive care facilities, and outpatient clinics. The company relies on high levels of innovation and collaboration with physicians, scientists, and other experts. The goal is to improve existing medical procedures, explore new applications for the technology, and optimize patient care. Masimo Corp's products are divided into different divisions that focus on various aspects of medical care. One example is the "Patient Monitoring" division, which offers various monitoring systems for vital signs such as respiration, pulse, and oxygen saturation. This includes products like the Rad-67 pulse oximeter or the Root patient monitor, which continuously monitor patients during treatment to enhance safety and effectiveness. Another division is "Anesthesia and Sedation," which focuses on solutions for anesthesiologists and intensive care specialists. Masimo Corp offers products such as the SedLine brain monitor or the EMMA main gas monitor, which enable physicians to control anesthesia depth more precisely and reduce the risk of complications. In addition to patient monitoring systems, Masimo Corp also provides solutions for neonatal care. The "Neonatal Care" division includes products like the Masimo Radical-7 pulse oximeter for monitoring premature infants or the Pronto-7 pulse oximeter for fast and accurate monitoring of newborns in the delivery room. Furthermore, Masimo Corp has developed products for monitoring surgical patients. The "Surgical and Minimally Invasive Monitoring" division, for example, offers the MOC-9 monitoring system for precise monitoring of hemodynamics during surgery. A unique product of Masimo Corp is also the Masimo SET sensor, which provides more accurate and reliable measurement of blood oxygen saturation than traditional pulse oximeter sensors. The company has filed over 100 patents worldwide for this technology and has been recognized with numerous awards and accolades. In summary, Masimo Corp is an innovative company specializing in improving medical care through the development and marketing of products for patient monitoring and treatment. With its state-of-the-art technologies and collaboration with experts in medical research, Masimo Corp sets standards for patient safety and treatment effectiveness. Masimo is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Masimo stock

Days Payable Outstanding (DPO) of Masimo is 64.63 in 2026.

Days Payable Outstanding (DPO) of Masimo changed from 84.65 to 64.63, representing a -23.65% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) Masimo since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s Masimo with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

Profitability — Masimo

All Key Metrics — Masimo